UK markets closed

Virpax Pharmaceuticals, Inc. (VRPX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.2500-0.2500 (-10.00%)
As of 02:02PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts0011
Avg. Estimate00-7.3-7.4
Low estimate00-7.3-7.4
High estimate00-7.3-7.4
Year ago EPS-5-6.5-12.97-7.3
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts0011
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202229/09/202229/09/202330/12/2023
Est. EPS-4.4-4.5-2.6-2.7
Actual EPS-5-6.5-5.1-3.9
Difference-0.6-2-2.5-1.2
Surprise %-13.60%-44.40%-96.20%-44.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate00-7.3-7.4
7 days ago00-7.3-7.4
30 days ago00-7.3-7.4
60 days ago00-0.73-0.74
90 days ago00-0.73-0.74
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesVRPXIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year43.70%N/AN/AN/A
Next year-1.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A